Top 10 In Vitro Diagnostic Solutions Companies in APAC 2022 - AllTest

Top 10 In Vitro Diagnostic Solutions Companies in APAC 2022 - AllTest

Excellent News!!!

Hangzhou AllTest Biotech Co., Ltd had been named one of the Top 10 In Vitro Diagnostic Solutions Companies in APAC 2022 by MedTech Outlook Magazine.

The goal of MedTech Outlook is to identify rising firms in the in vitro diagnostic solutions field who demonstrate skill in addressing market difficulties. The article may help our readers gain a better knowledge of AllTest and its unique value proposition in the in vitro diagnostic solutions environment. Especially in the field of drug misuse!

Hangzhou AllTest Biotech Co., Ltd ’s drugs of abuse rapid testing reagents can detect nearly 70 types of drugs and substances, covering most of the world’s drug types. “We have a wide range of drugs of abuse rapid test products compatible with Food and Drug Administration (FDA) and European health, safety, and environmental protection standards,” notes GaoFei, chairperson of Hangzhou AllTest Biotech Co., Ltd. The company offers these drugs of abuse rapid test kits throughout the Asia-Pacific region and even in other business regions to help global businesses create a motivated and healthy workforce.

MedTech Outlook’s aims to identify the emerging players in the in vitro diagnostic solutions space that showcase their expertise in solving impediments and overcoming market complexities. Moreover, The mission is to make innovative medical technology available to more people, while helping healthcare systems move towards a sustainable path. The write-up could shed some light to our readers to develop a thorough understanding of Hangzhou AllTest Biotech Co., Ltd and its unique value proposition in the in vitro diagnostic solutions landscape.

Link to the Magazine :

https://www.medicaltechoutlook.com/magazines/September2022/In_Vitro_Diagnostic_APAC/?digitalmagazine#page=12